HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells - Quiz - MDSpire

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

  • By

  • Cansu Yerinde

  • Jacqueline Keye

  • Hsiang-Jung Hsiao

  • Sibel Durlanik

  • Inka Freise

  • Franziska Nowak

  • Marilena Letizia

  • Stephan Schlickeiser

  • Benedikt Obermayer

  • Adrian Huck

  • Marie Friedrich

  • Hao Wu

  • Désirée Kunkel

  • Anja A. Kühl

  • Sebastian Bauer

  • Andreas Thiel

  • Ahmed N. Hegazy

  • Britta Siegmund

  • Rainer Glauben

  • Carl Weidinger

  • May 12, 2026

  • 0 min

Share

Original Source(s)

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

  • by Cansu Yerinde, Jacqueline Keye, Hsiang-Jung Hsiao, Sibel Durlanik, Inka Freise, Franziska Nowak, Marilena Letizia, Stephan Schlickeiser, Benedikt Obermayer, Adrian Huck, Marie Friedrich, Hao Wu, Désirée Kunkel, Anja A. Kühl, Sebastian Bauer, Andreas Thiel, Ahmed N. Hegazy, Britta Siegmund, Rainer Glauben, Carl Weidinger

  • May 12, 2026

Related Content

Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • by

  • February 13, 2026

  • 12 min
Multi-strategy feature selection and multi-model machine learning for prognostic prediction in primary gastric diffuse large B-cell lymphoma